Press Releases :: IceCure Medical Ltd. (ICCM)

Skip to main content Skip to section navigation Skip to footer

Jun 07, 2021 8:00 am EDT

IceCure Medical Announces Exclusive $6.6M Distribution Agreement to Sell ProSense™ Cryoablation System in Brazil

May 04, 2021 8:00 am EDT

Positive Interim Results from IceCure Medical's ICE3 Clinical Trial for Breast Cancer Treatment by Freezing with the ProSense® Cryoablation System Presented at the 2021 ASBrS Meeting

Apr 20, 2021 8:00 am EDT

IceCure Medical Announces Upcoming Presentation at the American Society of Breast Surgeons Annual Meeting

Apr 05, 2021 8:00 am EDT

IceCure Medical Granted FDA Breakthrough Device Designation for ProSense® Cryoablation System

Mar 03, 2021 8:00 am EST

IceCure to Present at the H.C. Wainwright Global Life Sciences Conference

Feb 17, 2021 8:00 am EST

IceCure Signs Exclusive Distribution Agreement with Rise General Trading, LCC, Expanding Market Reach Across the Middle East

Jan 05, 2021 8:00 am EST

IceCure Inks Expanded Distribution Agreement with Terumo Corporation for Thailand

Oct 05, 2020 8:00 am EDT

IceCure Expands Strategic Collaboration with Terumo: New Commercial Distribution Agreement Potentially Valued at over $7.0 Million

Aug 10, 2020 8:00 am EDT

IceCure Raises NIS 20.7 Million in Equity Share Offering; Received Oversubscribed Demand of NIS 24 Million

Apr 28, 2020 8:00 am EDT

IceCure's Global Expansion Accelerates; Tumor Freezing Product Now Approved for Market in India

Select a page:

rss_feed News RSS

IceCure Medical HQ: 7 Ha’Eshel St., PO Box 3163, Caesarea, 3079504, Israel

© 2023 All Rights Reserved IceCure Medical

Branding by

Terms of Use | Privacy | Last Updated: April 9, 2023